#1 Clinical Trials Search in Europe

Lung cancer metastatic – Diagnostics

Go back

Metastatic lung cancer represents the advanced stage of lung cancer where the disease has spread beyond the lungs to other parts of the body, requiring careful diagnostic evaluation to understand the extent of spread and guide treatment decisions.

Introduction: Who Should Undergo Diagnostics and When

Diagnosing metastatic lung cancer is a crucial step that helps doctors understand not only that cancer is present in the lungs, but also where it has traveled in the body. Metastatic lung cancer means that cancer cells from the original lung tumor have spread to distant organs or tissues, which is also called advanced or stage 4 lung cancer.[1] This is different from cancer that starts in another organ and spreads to the lungs—in that case, the cancer keeps the name of where it originally started.[2]

Many people find out they have metastatic lung cancer when they are first diagnosed, because lung cancer often causes no symptoms in its early stages. According to research, approximately 30 to 40 percent of people with non-small cell lung cancer already have metastatic disease by the time doctors detect it.[3] This happens because the lungs themselves do not have pain receptors, so a tumor growing there may not cause discomfort until it becomes large or spreads to other areas.[6]

You should seek diagnostic testing if you experience persistent symptoms that could suggest lung cancer or its spread. Common warning signs include a cough that does not go away, coughing up blood, chest pain, shortness of breath, frequent chest infections, or unexplained weight loss.[2] When lung cancer spreads to other parts of the body, symptoms depend on where the cancer has traveled. For example, bone pain might indicate spread to the bones, while headaches, vision changes, dizziness, or weakness in limbs could suggest the cancer has reached the brain.[6]

Anyone with a known history of lung cancer should remain vigilant even after treatment. Sometimes cancer comes back months or years after successful initial treatment—this is called recurrent cancer.[1] In such cases, new or changing symptoms warrant immediate medical attention and diagnostic evaluation to determine whether the cancer has returned and whether it has spread.

⚠️ Important
If you notice swelling in your face, neck, or arms along with breathlessness, headaches, or dizziness, contact your doctor immediately. These could be signs of superior vena cava obstruction, a serious complication where the tumor blocks a large vein in your chest.[14]

Diagnostic Methods for Identifying and Distinguishing Metastatic Lung Cancer

Health History and Physical Examination

The diagnostic journey typically begins with a thorough conversation between you and your doctor. Your health history includes information about your symptoms, any risk factors you may have, and all past medical events and problems.[2] Your doctor will ask detailed questions about symptoms that might suggest lung metastases, such as persistent cough, breathing difficulties, or pain in specific areas of your body.

During the physical examination, your doctor looks for signs that cancer may have spread. This might include listening to your lungs with a stethoscope, checking for swollen lymph nodes in your neck, or examining other parts of your body depending on your symptoms.[2] While these initial steps cannot confirm metastatic lung cancer on their own, they help guide which additional tests you may need.

Blood Tests

Blood tests play an important supporting role in diagnosing metastatic lung cancer, though they cannot confirm the diagnosis by themselves. These tests help doctors check your general health and understand how well certain organs are functioning.[2]

A complete blood count, or CBC, examines your blood cells and can reveal problems with your bone marrow. An electrolyte panel measures substances like sodium, potassium, and chloride, which helps identify kidney problems. Liver function tests look for signs that cancer might have spread to the liver.[2] Doctors may also measure oxygen saturation—the amount of oxygen in your blood—to see if your lungs are working properly.

If you have been treated for cancer before, your doctor might order tumor marker tests. These measure specific proteins in your body, and an increase in tumor marker levels could mean that the original cancer has returned and possibly spread to the lungs.[2]

Imaging Tests

Imaging tests create pictures of the inside of your body and are essential for diagnosing metastatic lung cancer. These tests show not only whether cancer is present in the lungs, but also whether it has spread to other organs.[2]

A chest x-ray is usually the first imaging test performed when you have symptoms like coughing or shortness of breath. Doctors use chest x-rays to look for lung tumors, although this test provides less detail than other imaging methods.[2]

A CT scan of the chest is a common and more detailed test for checking whether cancer has spread to the lungs. The CT scan provides cross-sectional images that show tumors more clearly than x-rays.[2] Doctors often use this test to see how many tumors are present, where they are located, and how large they are. Most lung metastases develop near the edges of the lungs and in the lower portions, called lobes.[2]

PET scans, or positron emission tomography scans, use a small amount of radioactive material to highlight areas of cancer activity throughout the body. This test is particularly useful because it can show whether cancer has spread beyond the lungs to places like the bones, liver, or brain.[4]

MRI scans, which use magnets and radio waves instead of radiation, are especially helpful for examining the brain and spinal cord. If your doctor suspects that lung cancer has spread to your brain, an MRI can provide detailed images to confirm this.[2]

Other specialized scans include bone scans to check if cancer has spread to the skeleton, and various ultrasound examinations to look at organs like the liver or lymph nodes.[4]

Biopsy and Tissue Analysis

While imaging tests can strongly suggest metastatic lung cancer, a biopsy is the only way to confirm the diagnosis with certainty. During a biopsy, doctors remove a small sample of tissue so it can be examined under a microscope by a specialist called a pathologist.[3]

When looking at metastatic lung cancer cells under the microscope, the pathologist can see that these cells have the same features as the original lung cancer cells. This confirms that the cancer in another part of your body actually started in the lung, rather than being a new, separate cancer.[3]

There are different ways to perform a biopsy depending on where the suspected metastases are located. For tumors in the lung itself, doctors might use bronchoscopy—a procedure where a thin tube with a camera is inserted through your mouth or nose into your airways. For tumors in other organs, doctors might use a needle inserted through your skin, or they might perform a surgical biopsy.[4]

Additional Diagnostic Procedures

If fluid has built up around your lungs—a condition called pleural effusion—your doctor may perform a procedure called thoracentesis to drain and test this fluid. Analyzing the fluid can reveal whether cancer cells are present.[4]

For certain situations, doctors might recommend mediastinoscopy, a surgical procedure to examine and take samples from lymph nodes in the chest. This helps determine whether cancer has spread to these important structures.[4]

Understanding Where Lung Cancer Spreads

Knowing the common places where lung cancer spreads helps doctors focus their diagnostic efforts. Lung cancer most frequently travels to nearby lymph nodes, the brain, bones, liver, and the adrenal glands (small organs located near the kidneys).[1] It can also spread to the pleura—the thin layers of tissue that wrap around the outside of the lungs—and to other parts of the same lung or the opposite lung.[6]

The pattern of spread varies depending on the type of lung cancer. Some cancers spread through the bloodstream (hematogenous spread), while others travel through the lymphatic system. A few can directly invade nearby tissues.[4] Understanding these patterns helps doctors choose the most appropriate diagnostic tests for each person’s situation.

Diagnostics for Clinical Trial Qualification

If you are considering joining a clinical trial for metastatic lung cancer, you will need to undergo specific diagnostic tests that meet the trial’s enrollment criteria. Clinical trials test new treatments or combinations of treatments, and they have strict requirements about who can participate to ensure the safety of participants and the accuracy of the study results.

Confirming Cancer Stage and Extent

Clinical trials for metastatic lung cancer typically require confirmation that the cancer has indeed spread beyond the lungs. This usually means you will need comprehensive imaging studies—often including CT scans, PET scans, or MRI scans—to document exactly where the cancer has traveled and how extensive the spread is.[6]

Some trials focus on oligometastatic lung cancer, which means the cancer has spread to only a limited number of sites—typically five or fewer locations, though sometimes as many as ten or more.[6] If you are being considered for such a trial, imaging tests must clearly show the number and location of metastases to confirm you meet this specific definition.

Molecular and Genetic Testing

Many modern clinical trials for metastatic lung cancer require information about the genetic and molecular characteristics of your tumor. Doctors perform these tests on tissue samples obtained through biopsy. The tests look for specific changes, or mutations, in the cancer cells’ genetic material.

For example, some trials enroll only patients whose tumors have particular genetic changes that make them likely to respond to targeted therapies. Common genetic markers tested include changes in genes like EGFR, ALK, ROS1, and others. These tests help match patients to treatments that are most likely to work for their specific type of cancer.[4]

Baseline Health Assessments

Before you can join a clinical trial, doctors need to establish your baseline health status. This typically includes comprehensive blood tests to check how well your organs are functioning, particularly your kidneys, liver, and bone marrow. These tests ensure that you are healthy enough to safely receive the trial treatment and help doctors monitor for side effects later.[2]

Many trials require assessment of your overall physical condition using standardized scales. Doctors evaluate how well you can perform daily activities and your general quality of life. This information helps determine if the experimental treatment is appropriate for you and provides a starting point for measuring whether the treatment improves or affects your well-being.

Repeated Testing During Trials

Once enrolled in a clinical trial, you will undergo regular diagnostic tests throughout the study period. These repeated assessments—which might include imaging scans, blood tests, and physical examinations—help researchers understand whether the treatment is working, monitor for side effects, and gather data about the cancer’s response to treatment.

The frequency and type of testing during a trial are more intensive than in standard care because researchers need detailed information to evaluate the experimental treatment’s effectiveness and safety. While this means more medical appointments and tests, this careful monitoring also means any problems or changes in your condition are detected quickly.

⚠️ Important
Clinical trials are researching whether patients with more advanced metastatic lung cancers could benefit from aggressive treatment approaches that combine radiation, surgery, and drug therapies. While these treatments cannot cure metastatic lung cancer in most cases, they may help control the disease for longer periods, and in rare cases involving oligometastatic cancer, they might offer a cure.[6]

Prognosis and Survival Rate

Prognosis

The prognosis for metastatic lung cancer is serious, as advanced cancer typically cannot be cured. However, this does not mean there is no hope—treatment can often control the disease, reduce symptoms, and improve quality of life for some time.[1] Thanks to advances in treatment over recent decades, including new targeted drugs, immunotherapies, improved radiation technologies, and less invasive surgeries, patients with metastatic lung cancer are living longer than they did ten years ago.[6]

Several factors influence how the disease will progress for each individual person. The outlook differs based on what type of lung cancer you have (small cell or non-small cell), where exactly the cancer has spread, your overall health and physical condition, and how well the cancer responds to treatment. Your age, other medical conditions you may have, and your body’s response to therapy also play important roles in determining outcomes.

Understanding your prognosis is a personal decision. Some people want detailed information about what to expect, while others prefer to know less and focus on living day by day. There is no right or wrong approach—what matters is what helps you cope best. Your doctor and specialist nurse are the best people to discuss your individual situation with, as they have all the information about your specific cancer and circumstances.[1]

Research continues to improve outcomes for metastatic lung cancer. Scientists have discovered that certain metastatic cancers, particularly oligometastatic cancers where the disease has spread to only a limited number of sites, can sometimes be controlled for longer periods with more aggressive treatment approaches. In rare cases, these cancers can even be cured.[6] This represents hope that ongoing research will continue to extend and improve the lives of people with metastatic lung cancer.

Survival Rate

Survival rates for metastatic lung cancer vary widely depending on many individual factors. While metastatic or stage 4 lung cancer has historically had lower survival rates compared to earlier-stage disease, it is important to remember that statistics represent averages across large groups of people and may not reflect your personal situation.

Your doctor is the best person to discuss survival expectations with you, as they can consider your specific type of cancer, its molecular characteristics, where it has spread, your overall health, and how you are responding to treatment. These individual factors make a significant difference in outcomes, and general statistics cannot account for your unique circumstances.[1]

It is also worth noting that survival statistics often reflect outcomes from patients who were diagnosed and treated several years ago, before many of the newest treatments became available. As treatments continue to improve—particularly with the development of targeted therapies and immunotherapies—outcomes are becoming better than what older statistics suggest.[6]

If understanding survival statistics is important to you, speak with your healthcare team who can provide information relevant to your specific situation, explain what the numbers mean, and help put them in context with current treatment advances.

Ongoing Clinical Trials on Lung cancer metastatic

  • Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Spain

References

https://www.cancerresearchuk.org/about-cancer/lung-cancer/metastatic/what-is

https://cancer.ca/en/cancer-information/cancer-types/metastatic/lung-metastases

https://www.medicalnewstoday.com/articles/316384

https://www.ncbi.nlm.nih.gov/books/NBK553111/

https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620

https://www.uchicagomedicine.org/cancer/types-treatments/lung-cancer/metastatic-lung-cancer-treatment

More information about
Lung cancer metastatic:

FAQ

What is the difference between metastatic lung cancer and cancer that spreads to the lungs from somewhere else?

Metastatic lung cancer means cancer that started in the lung and then spread to other parts of the body. If cancer from another organ (like breast or colon) spreads to the lungs, it is still called by its original name—breast cancer or colon cancer—not lung cancer. The cancer cells keep the characteristics of where they originally started, even when they travel to a new location.[2][6]

How do doctors know if my lung cancer has spread without doing surgery?

Doctors use imaging tests like CT scans, PET scans, MRI scans, and bone scans to see if cancer has spread beyond the lungs. These tests create detailed pictures of your internal organs and can show tumors in different parts of your body. Blood tests also provide clues about organ function. While imaging strongly suggests spread, a biopsy—where doctors take a small tissue sample—is the only way to confirm with certainty that cancer is present in a particular location.[2][4]

Where does lung cancer usually spread to first?

Lung cancer most commonly spreads to nearby lymph nodes first, then to more distant sites including the brain, bones, liver, and adrenal glands (small glands near the kidneys). It can also spread to the pleura (the tissue layers covering the lungs) or to other parts of the same lung or the opposite lung. However, the pattern of spread can vary between different types of lung cancer and between individual patients.[1][6]

Will I need many diagnostic tests if I’m joining a clinical trial?

Yes, clinical trials typically require more extensive testing than standard care. You will need comprehensive imaging to confirm where the cancer has spread, tissue samples for genetic and molecular testing, and detailed blood work to assess your overall health. During the trial, you will have regular repeated tests to monitor how the treatment is working and check for side effects. While this means more medical appointments, it also means careful monitoring of your condition.[2][6]

Can diagnostic tests cause the cancer to spread?

No, diagnostic tests do not cause cancer to spread. This is a common worry, but procedures like biopsies, imaging tests, and blood draws do not make cancer travel to new locations in your body. These tests are designed to be as safe as possible, and the benefits of getting an accurate diagnosis far outweigh any small risks associated with the procedures.[4]

🎯 Key Takeaways

  • • Metastatic lung cancer often causes no symptoms until it has already spread because lungs lack pain receptors, which is why 30-40% of cases are metastatic when first diagnosed.
  • • Imaging tests like CT scans and PET scans show where cancer has spread, but only a biopsy can confirm with certainty that cancer is present by examining actual tissue under a microscope.
  • • Cancer cells from metastatic lung cancer look identical to the original lung cancer cells no matter where they travel—this unique characteristic helps pathologists confirm the diagnosis.
  • • Modern treatments have significantly improved survival compared to a decade ago, with targeted therapies and immunotherapies offering new hope for people with metastatic disease.
  • • Oligometastatic lung cancer—where spread is limited to five or fewer sites—can sometimes be controlled for longer periods or even cured with aggressive treatment approaches combining radiation, surgery, and drugs.
  • • Clinical trials require extensive diagnostic testing including genetic analysis of tumor tissue to match patients with treatments most likely to work for their specific cancer type.
  • • Symptoms of spread depend on location—bone pain suggests bones, headaches or vision changes suggest brain, and swollen face or neck might indicate a blocked major vein requiring immediate attention.
  • • Your doctor and specialist nurse are your best resources for understanding what your personal prognosis means, as general statistics cannot account for your individual circumstances and newer treatments.

Connected medications: